| 1 |
35099304 | Cytochrome P450 3A5 polymorphism affects the metabolism of sorafenib and its toxicity for hepatocellular carcinoma cells in vitro. | 2022 Jan-Dec |
3 |
| 2 |
30231963 | Specific CYP450 Genotypes in the Chinese Population Affect Sorafenib Toxicity in HBV/HCV-associated Hepatocellular Carcinoma Patients. | 2018 Aug |
1 |
| 3 |
23237922 | Risk factors for sorafenib-induced high-grade skin rash in Japanese patients with advanced renal cell carcinoma. | 2013 Mar |
1 |
| 4 |
22912756 | Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary study. | 2012 |
1 |
| 5 |
21266595 | Sorafenib and sunitinib, two anticancer drugs, inhibit CYP3A4-mediated and activate CY3A5-mediated midazolam 1'-hydroxylation. | 2011 May |
3 |